Your browser doesn't support javascript.
loading
Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study.
Xiang, Jinyu; Gong, Wenjing; Sun, Ping; Wang, Xuan; Liu, Aina.
Affiliation
  • Xiang J; Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Gong W; Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Sun P; Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Wang X; Medical Department, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Liu A; Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
J Gastrointest Oncol ; 13(6): 2874-2884, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36636085
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies Language: En Journal: J Gastrointest Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies Language: En Journal: J Gastrointest Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: China